Relmada Therapeutics

Relmada Therapeutics

Relmada Therapeutics

Relmada (OTCQB: $RLMD) is focused on developing novel versions of proven drug products together with new chemical entities for the treatment of chronic pain.
Founded
2007
Raised
$18.1M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$15,051,110
Venture capital - 2014
$3,000,000
Venture capital (Series A) - 2012
Team Size
10+
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Relmada Therapeutics makes some noise.